These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 17291836)

  • 21. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
    Hoyles RK; Ellis RW; Wellsbury J; Lees B; Newlands P; Goh NS; Roberts C; Desai S; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM
    Arthritis Rheum; 2006 Dec; 54(12):3962-70. PubMed ID: 17133610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A retrospective analysis of biofilm antibiotic susceptibility testing: a better predictor of clinical response in cystic fibrosis exacerbations.
    Keays T; Ferris W; Vandemheen KL; Chan F; Yeung SW; Mah TF; Ramotar K; Saginur R; Aaron SD
    J Cyst Fibros; 2009 Mar; 8(2):122-7. PubMed ID: 19064337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of intravenous meropenem and tobramycin versus ceftazidime and tobramycin in cystic fibrosis.
    Latzin P; Fehling M; Bauernfeind A; Reinhardt D; Kappler M; Griese M
    J Cyst Fibros; 2008 Mar; 7(2):142-6. PubMed ID: 17766190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation.
    Etherington C; Naseer R; Conway SP; Whitaker P; Denton M; Peckham DG
    J Cyst Fibros; 2014 Jan; 13(1):49-55. PubMed ID: 23891398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral vs IV corticosteroids for in-hospital treatment of COPD exacerbations.
    Tashkin DP
    Chest; 2007 Dec; 132(6):1728-9. PubMed ID: 18079214
    [No Abstract]   [Full Text] [Related]  

  • 26. Oral corticosteroid therapy in cystic fibrosis patients hospitalized for pulmonary exacerbation: a pilot study.
    Dovey M; Aitken ML; Emerson J; McNamara S; Waltz DA; Gibson RL
    Chest; 2007 Oct; 132(4):1212-8. PubMed ID: 17646219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exhaled breath condensate pH and ammonia in cystic fibrosis and response to treatment of acute pulmonary exacerbations.
    Newport S; Amin N; Dozor AJ
    Pediatr Pulmonol; 2009 Sep; 44(9):866-72. PubMed ID: 19670404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pyrosequencing reveals transient cystic fibrosis lung microbiome changes with intravenous antibiotics.
    Smith DJ; Badrick AC; Zakrzewski M; Krause L; Bell SC; Anderson GJ; Reid DW
    Eur Respir J; 2014 Oct; 44(4):922-30. PubMed ID: 25034564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhaled antibiotics in Cystic Fibrosis (CF) and non-CF bronchiectasis.
    Tay GT; Reid DW; Bell SC
    Semin Respir Crit Care Med; 2015 Apr; 36(2):267-86. PubMed ID: 25826593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Duration of effect of intravenous antibiotics on spirometry and sputum cytokines in children with cystic fibrosis.
    Cunningham S; McColm JR; Mallinson A; Boyd I; Marshall TG
    Pediatr Pulmonol; 2003 Jul; 36(1):43-8. PubMed ID: 12772222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of long term antibiotics in chronic respiratory diseases.
    Suresh Babu K; Kastelik J; Morjaria JB
    Respir Med; 2013 Jun; 107(6):800-15. PubMed ID: 23522403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectrum Of Pulmonary Exacerbation In Children And Adolescent With Cystic Fibrosis And Physicians' Practices: Experience From Tertiary Care Center From Lower-Middle Income Country.
    Aziz DA; Shahid S; Alam A; Aziz N; Iftikhar H; Mir F
    J Ayub Med Coll Abbottabad; 2021; 33(3):363-367. PubMed ID: 34487639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time course and recovery of arterial blood gases during exacerbations in adults with Cystic Fibrosis.
    Waterhouse DF; McLaughlin AM; Gallagher CG
    J Cyst Fibros; 2009 Jan; 8(1):9-13. PubMed ID: 18718821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-reactive protein in acute pulmonary exacerbations of patients with cystic fibrosis.
    Friesen CA; Wiens LA; Burry VF; Portnoy J; Roberts CC
    Pediatr Pulmonol; 1995 Oct; 20(4):215-9. PubMed ID: 8606850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous antibiotics at home in children with cystic fibrosis.
    David TJ
    J R Soc Med; 1989 Mar; 82(3):130-1. PubMed ID: 2649673
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of rescue oral glucocorticoid therapy during inpatient cystic fibrosis exacerbations.
    Muirhead CA; Lanocha N; Markwardt S; MacDonald KD
    Pediatr Pulmonol; 2021 May; 56(5):891-900. PubMed ID: 33289316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypersensitivity reactions to intravenous antibiotics in cystic fibrosis.
    Wright MFA; Bush A; Carr SB
    Paediatr Respir Rev; 2018 Jun; 27():9-12. PubMed ID: 29703693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variation in treatment preferences of pulmonary exacerbations among Australian and New Zealand cystic fibrosis physicians.
    Currie G; Tai A; Snelling T; Schultz A
    BMJ Open Respir Res; 2021 Jul; 8(1):. PubMed ID: 34266854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral corticosteroids and bone pain after pamidronate in adults with cystic fibrosis.
    Haworth CS; Selby PL; Webb AK; Adams JE; Freemont TJ
    Lancet; 1999 May; 353(9167):1886. PubMed ID: 10359445
    [No Abstract]   [Full Text] [Related]  

  • 40. Intravenous antibiotic therapy in cystic fibrosis: in hospital or at home?
    Ninan TK; Russell G
    Respir Med; 1994 Feb; 88(2):158-9. PubMed ID: 8031361
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.